$128.18-0.91 (-0.70%)
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy.
Constellation Brands, Inc. in the Consumer Defensive sector is trading at $128.18 with a market capitalization of $21.9B. Wall Street consensus targets $170.83 (23 analysts), implying a +33.3% move over the next 12 months. The stock is currently near its 52-week low of $126.45, remaining 10.6% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.43B↑ | $1.92B↓ | $2.22B↓ | $2.48B↓ | $2.52B |
| Gross Profit | $1.32B↑ | $951.70M↓ | $1.18B↓ | $1.31B↑ | $1.27B |
| Operating Income | $863.60M↑ | $531.20M↓ | $692.00M↓ | $874.00M↑ | $765.90M |
| Net Income | $653.80M↑ | $201.80M↓ | $502.80M↑ | $466.00M↓ | $516.10M |
Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It offers beer under the Corona Extra, Corona Familiar, Corona Sun...

Beer sales have been down, but the company's brand power appears intact.

STZ's premium strategy, strong beer portfolio and brand investments position it for market share gains and long-term growth.

AVO's Q3 outlook faces pressure from lower avocado prices, sourcing costs and blueberry headwinds, though integration and demand offer support.

BF.B's Q1 EPS meets estimates, but sales fall 1% y/y as tequila, used barrels and Korbel weigh, while RTD sales jump 20%.

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Academic risk and quality models computed from STZ's own filings and price history, not from analyst opinion.
Mixed: 6 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z in the 1.81 to 2.99 grey zone, the band where the model gives no clear bankruptcy verdict.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.